Next Generation Mapping a novel approach that enables the detection of unbalanced as well as balanced structural variants

Archive ouverte

El Khattabi, Laïla | Schluth-Bolard, Caroline | Chatron, Nicolas | Baatout, Imane | Lebbar, Aziza | Montagnon, Martine | Duffourd, Yannis | Vitobello, Antonio | Callier, Patrick | Deleuze, Jean-François | Sanlaville, Damien | Dupont, Jean Michel

Edité par CCSD -

International audience. Structural variants (SVs) include large unbalanced (CNVs) and balanced variants (insertions, inversions and translocations). Whereas the detection of unbalanced SVs has been significantly improved by technological breakthrough such as Chromosomal Microarray Analysis (CMA), the detection of balanced SVs still relies on karyotype despite its very low resolution. Massively parallel sequencing enables the detection of some SVs but its use in clinical setting is yet limited by technical and computational challenges, among which the read length. Next Generation Mapping using the Bionano system is a novel non-sequencing based technology. Long high molecular weight DNA fragments are labelled at specific sites and then stretched out into a nano-channel system for fluorescence reading. The labelling pattern is then compared to a reference genome pattern allowing for the identification of SVs without complex bioinformatic analyses. We sought to evaluate the performance of this technology and its ease of use in a routine cytogenetic laboratory. Our study includes 29 patients bearing balanced (11 translocations and 4 inversions) or unbalanced SVs (1 unbalanced translocation, 7 CNVs ranging from 500kb to 4Mb), complex chromosomal rearrangements (n=4), isochromosomes (n=2) and one case of aneuploidy, all previously identified by karyotype or CMA. The results are analysed blindly and then compared to karyotype or CMA results. Preliminary data on four samples show reliable detection of the expected SVs. This approach has the potential to improve the resolution of the pangenome detection of different sorts of SVs, and could hence complement or even replace karyotype and CMA as a unique, simple and comprehensive test. This would have a significant clinical impact for diseases in which balanced SVs are mainly involved, such as reproductive diseases and recurrent miscarriages.

Consulter en ligne

Suggestions

Du même auteur

Identification and characterization of new imprinted genes in the human placenta. Identification et caractérisation de nouveaux gènes soumis à l’empreinte parentale dans le placenta humain

Archive ouverte | El Khattabi, Laïla | CCSD

Parental imprinting is a complex epigenetic phenomenon that regulates the mono-allelic expression of some genes in a parent-of-origin way. Imprinted genes (IG) contribute to placental and fetal development. These genes are highly ...

Performance of Semiconductor sequencing platform for non-invasive prenatal genetic screening for fetal aneuploidies: results from a multicenter prospective cohort study in a clinical setting

Archive ouverte | Allach El Khattabi, Laïla | CCSD

International audience. Objectives To validate and evaluate an integrated protocol for non‐invasive prenatal genetic screening (NIPS) for common fetal aneuploidies in a clinical setting, using the semiconductor sequ...

Could sperm grade under high magnification condition predict IMSI clinical outcome?

Archive ouverte | Sifer, Christophe | CCSD

International audience. Objective: The aim of this study was to examine whether injection of first-best morphology grade selected spermatozoa improves live birth rate (LBR) compared to intracytoplasmic morphological...

Chargement des enrichissements...